|
XB--494199
Papers associated with grin1 (and Disease Ontology)
???pagination.result.count???
???pagination.result.page??? 1
| Sort Newest To Oldest | Sort Oldest To Newest |
Advancements in the use of xenopus oocytes for modelling neurological disease for novel drug discovery., O'Connor EC, Kambara K, Bertrand D., Expert Opin Drug Discov. February 1, 2024; 19 (2): 173-187.  |
|
Recurrent seizure-related GRIN1 variant: Molecular mechanism and targeted therapy., Xu Y, Song R, Chen W, Strong K, Shrey D, Gedela S, Traynelis SF, Zhang G, Yuan H., Ann Clin Transl Neurol. July 1, 2021; 8 (7): 1480-1494.  |
|
Disruption of Cav1.2-mediated signaling is a pathway for ketamine-induced pathology., Chen H, Vandorpe DH, Xie X, Alper SL, Zeidel ML, Yu W., Nat Commun. August 28, 2020; 11 (1): 4328.  |
|
GRIN2B mutations in West syndrome and intellectual disability with focal epilepsy., Lemke JR, Hendrickx R, Geider K, Laube B, Schwake M, Harvey RJ, James VM, Pepler A, Steiner I, Hörtnagel K, Neidhardt J, Ruf S, Wolff M, Bartholdi D, Caraballo R, Platzer K, Suls A, De Jonghe P, Biskup S, Weckhuysen S., Ann Neurol. January 1, 2014; 75 (1): 147-54.  |
|
Molecular cloning and chromosomal localization of the key subunit of the human N-methyl-D-aspartate receptor., Karp SJ, Masu M, Eki T, Ozawa K, Nakanishi S., J Biol Chem. February 15, 1993; 268 (5): 3728-33. |
???pagination.result.page??? 1